Correlia Biosystems

Correlia Biosystems

Protein tests company based in Berkeley founded by Akwasi Apori

Overview

Correlia Biosystems develops a proteomics platform. Their first commercial platform is for rapid detection of protein biomarkers providing high resolution and granular data from research, drug development, diagnostics, and personalized medicine. Correlia is a company within JLABS, the external R&D and innovation arm of Johnson & Johnson.

History and Technology

The company was founded at UC Berkeley from 2 post-docs and a graduate student from the Herr Lab. The core technology they developed enabled rapid quantification of protein biomarker panels in under 15 min from only 2 microliters of sample. Correlia Biosystems uses microfluidics and integrates assays such as ELISA and other immunoassays into rapid, automated and portable platforms for pharm and diagnostic applications.

Correlia received an NIH Small Business Innovation Research Grant in 2014 for the development of an electrokinetic lateral flow test (left) for diagnosing sickle cell disease and trait. The device is designed to be used at the point-of-care in work in low resource settings. The company collaborated with the Sickl Cell Foundation of Ghana on the project.

Fundraising

Correlia launched in the inaugural class of the Foundry incubator at UC Berkeley. During this time they were able to secure grants from the NIH, NSF, and other sources totaling $875K which was used to develop the core technology for commercial use. In 2018, Correlia participated in the Y Combinator W2018 cohort to launch a seed fundraising round.

Timeline

People

Name
Role
LinkedIn

HR Correlia

Employee

Jonathan Goldick

Advisor

Patrick Scaglia

Advisor

QB3@953 San Francisco

Incubator

Ramphis Castro

Investor

Founder

Will Kruka

Advisor

Zeenat Patrawala

Advisor

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.